| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |